Changing pertussis epidemiology: Everything old is new again

Journal of Infectious Diseases

Volumn 209, Issue 7, 2014, Pages 978-981

  Clark, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bordetella pertussis; epidemiology; immunization; public health; vaccination; Whooping cough

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

AGE; BACTERIAL IMMUNITY; BORDETELLA PERTUSSIS; CHILD DEATH; DIPHTHERIA; DRUG EFFICACY; EPIDEMIC; HUMAN; INCIDENCE; INFECTION RATE; PERTUSSIS; PRIORITY JOURNAL; PROTECTION; REVIEW; TETANUS; UNITED STATES; VACCINATION;

BORDETELLA PERTUSSIS; EPIDEMIOLOGY; IMMUNIZATION; PUBLIC HEALTH; VACCINATION; WHOOPING COUGH;

COMMUNICABLE DISEASES, EMERGING; HUMANS; IMMUNOLOGIC MEMORY; PERTUSSIS VACCINE; TIME FACTORS; VACCINES, ACELLULAR; WHOOPING COUGH; WORLD HEALTH;

EID: 84898968029     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu001     Document Type: Review

References (23)

1. Clark TA, Messonnier NE, Hadler SC. Pertussis control: Time for something new? Trends Microbiol 2012; 20:211-3
2. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:S58-61
3. Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: A decision analysis. Pediatrics 2013; 131:e1748-56
4. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 2008; 121:484-92
5. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29:209-15
6. Skoff TH, Cohn AC, Clark TA, Messonnier NEMartin SW. Early Impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med 2012; 166:344-9
7. CDC. Summary of notifiable diseases-United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 59:1-111
8. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012; 161:1091-6
9. CDC. Pertussis epidemic-Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517-22
10. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience. Pediatrics 2001; 108:E81
11. Lugauer S, Heininger U, Cherry JD, Stehr K. Long-Term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr 2002; 161: 142-6. (Pubitemid 34169862
12. Bisgard KM, Rhodes P, Connelly BL, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116:e285-94
13. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126-32
14. Klein NP, Bartlett J, Rowhani-Rahbar A, FIreman B, Baxter R.Waning protection after fifth dose of acellular pertussis vaccine in children. N Eng J Med 2012; 367:1012-9
15. Spokes PJ, Quinn HE, McAnulty JM. Review of the 2008-2009 pertussis epidemic in NSW: Notifications and hospitalisations. N S W Public Health Bull 2010; 21:167-73
16. Quinn HE, Mahajan D, Hueston L, et al. The seroepidemiology of pertussis in NSW: Fluctuating immunity profiles related to changes in vaccination schedules. N S W Public Health Bull 2011; 22:224-9
17. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012; 308:454-6
18. Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 2013; 368:581-2
19. Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: Waning immunity and pathogen adaptation-Two sides of the same coin. Epidemiol Infect 2013:1-10
20. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis 2012; 18:1248-55
21. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012; 19: 1703-4
22. Bodilis H, Guiso N. Virulence of pertactinnegative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 2013; 19: 471-4
23. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013; 368:583-4